These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32933624)

  • 1. [Current status of readmission of neonates with hyperbilirubinemia and risk factors for readmission].
    Xiao WX; Yang T; Zhang L
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Sep; 22(9):948-952. PubMed ID: 32933624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Readmission for neonatal hyperbilirubinemia in an area with a high prevalence of glucose-6-phosphate dehydrogenase deficiency: A hospital-based retrospective study.
    Al-Omran A; Al-Abdi S; Al-Salam Z
    J Neonatal Perinatal Med; 2017; 10(2):181-189. PubMed ID: 28409762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predischarge bilirubin screening in glucose-6-phosphate dehydrogenase-deficient neonates.
    Kaplan M; Hammerman C; Feldman R; Brisk R
    Pediatrics; 2000 Mar; 105(3 Pt 1):533-7. PubMed ID: 10699105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic follow-up of hyperbilirubinemia in neonates with a gestational age of 35 to 37 weeks.
    Punaro E; Mezzacappa MA; Facchini FP
    J Pediatr (Rio J); 2011; 87(4):301-6. PubMed ID: 21655685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperbilirubinemia among African American, glucose-6-phosphate dehydrogenase-deficient neonates.
    Kaplan M; Herschel M; Hammerman C; Hoyer JD; Stevenson DK
    Pediatrics; 2004 Aug; 114(2):e213-9. PubMed ID: 15286259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilirubin conjugation, reflected by conjugated bilirubin fractions, in glucose-6-phosphate dehydrogenase-deficient neonates: a determining factor in the pathogenesis of hyperbilirubinemia.
    Kaplan M; Muraca M; Hammerman C; Vilei MT; Leiter C; Rudensky B; Rubaltelli FF
    Pediatrics; 1998 Sep; 102(3):E37. PubMed ID: 9724685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single dose of Sn-mesoporphyrin prevents development of severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns.
    Kappas A; Drummond GS; Valaes T
    Pediatrics; 2001 Jul; 108(1):25-30. PubMed ID: 11433050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is it accurate to separate glucose-6-phosphate dehydrogenase activity in neonatal hyperbilirubinemia as deficient and normal?
    Kilicdag H; Gökmen Z; Ozkiraz S; Gulcan H; Tarcan A
    Pediatr Neonatol; 2014 Jun; 55(3):202-7. PubMed ID: 24326153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose-6-phosphate dehydrogenase deficiency in neonatal indirect hyperbilirubinemia.
    Atay E; Bozaykut A; Ipek IO
    J Trop Pediatr; 2006 Feb; 52(1):56-8. PubMed ID: 15917260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of inpatient rebound bilirubin levels in infants readmitted after birth hospitalization for hyperbilirubinemia.
    Berkwitt A; Osborn R; Grossman M
    Hosp Pediatr; 2015 Feb; 5(2):74-8. PubMed ID: 25646199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Readmission of breastfed infants in the first 2 weeks of life.
    Hall RT; Simon S; Smith MT
    J Perinatol; 2000; 20(7):432-7. PubMed ID: 11076327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004).
    Johnson L; Bhutani VK; Karp K; Sivieri EM; Shapiro SM
    J Perinatol; 2009 Feb; 29 Suppl 1():S25-45. PubMed ID: 19177057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and causes of severe neonatal hyperbilirubinemia in Canada.
    Sgro M; Campbell D; Shah V
    CMAJ; 2006 Sep; 175(6):587-90. PubMed ID: 16966660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns using an inhibitor of bilirubin production, Sn-mesoporphyrin.
    Valaes T; Drummond GS; Kappas A
    Pediatrics; 1998 May; 101(5):E1. PubMed ID: 9565434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome analysis of jaundice fast-track system implementation in Thammasat University Hospital.
    Tanticharoenwiwat P; Techasatid W
    J Med Assoc Thai; 2014 May; 97(5):500-5. PubMed ID: 25065088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors relating to readmission of term and near-term neonates in the first two weeks of life. Early Discharge Survey Group of the Health Professional Advisory Board of the Greater New York Chapter of the March of Dimes.
    Brown AK; Damus K; Kim MH; King K; Harper R; Campbell D; Crowley KA; Lakhani M; Cohen-Addad N; Kim R; Harin A
    J Perinat Med; 1999; 27(4):263-75. PubMed ID: 10560077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant weight loss in breastfed term infants readmitted for hyperbilirubinemia.
    Salas AA; Salazar J; Burgoa CV; De-Villegas CA; Quevedo V; Soliz A
    BMC Pediatr; 2009 Dec; 9():82. PubMed ID: 20043852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of unplanned readmission of neonates within 31 days after discharge from the neonatal intensive care unit and risk factors for readmission.
    Zheng QM; Hua WZ; Zhou JX; Jiang LP
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Mar; 24(3):314-318. PubMed ID: 35351264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal hyperbilirubinemia associated with glucose-6-phosphate dehydrogenase deficiency in Sephardic-Jewish neonates: incidence, severity, and the effect of phototherapy.
    Kaplan M; Abramov A
    Pediatrics; 1992 Sep; 90(3):401-5. PubMed ID: 1518696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-6-phosphate dehydrogenase deficiency and kernicterus of South-East anatolia.
    Katar S
    J Pediatr Hematol Oncol; 2007 May; 29(5):284-6. PubMed ID: 17483701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.